NCT02529202View on ClinicalTrials.gov

Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

January 31, 2017

Conditions
Hypoxic-ischemic Encephalopathy
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine infusion

Trial Locations (1)

98015

Seattle Children's Hospital, Seattle

All Listed Sponsors
lead

Seattle Children's Hospital

OTHER

NCT02529202 - Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia | Biotech Hunter | Biotech Hunter